Pay in 4 interest-free payments of $5.53 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Each batch undergoes testing for potency, purity, sterility, and the presence of impurities before release
Individualized targets: Glycemic targets should be individualized to balance efficacy and safety, particularly in patients with advanced disease or multiple comorbidities
The maximum FDA-approved subcutaneous dose is 2.4 mg weekly (Wegovy) for weight management
The variety of medication formats (injections, drops, lozenges) is frequently cited as a reason for choosing Shed over competitors
When you understand how these two peptides work together, you can make a confident decision along with a trained medical provider to see if this therapy fits your goals
Semaglutide and tirzepitide is administered via subcutaneous injection once per week using a pre-filled syringe
